Position in AZN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$395,037,171
New position
Shares Held
2,003,028
first reported quarter
Ownership
0.129%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 78.52251690939916.ToString("F0")%
Shared 0.ToString("F0")%
None 21.47748309060083.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $3,227,839,157 across 16 Drug Manufacturers - General names. AZN ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
789,744 | $726,382,830 | |
| 2 | JNJ |
Johnson & Johnson
|
2,700,881 | $660,203,341 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
2,003,028 | $395,037,171 | |
| 4 | ABBV |
AbbVie Inc.
|
1,506,385 | $327,623,666 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,526,631 | $303,928,435 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,543,724 | $275,576,850 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,067,837 | $148,824,436 | |
| 8 | PFE |
Pfizer Inc
|
4,737,650 | $133,033,205 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $395,037,171 | 2,003,028 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||